191 related articles for article (PubMed ID: 30391932)
1. MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves' disease.
Zhang D; Qiu X; Li J; Zheng S; Li L; Zhao H
Biol Chem; 2019 Apr; 400(5):639-650. PubMed ID: 30391932
[TBL] [Abstract][Full Text] [Related]
2. SIRT1-Regulated Abnormal Acetylation of FOXP3 Induces Regulatory T-Cell Function Defect in Hashimoto's Thyroiditis.
Yang X; Lun Y; Jiang H; Liu X; Duan Z; Xin S; Zhang J
Thyroid; 2018 Feb; 28(2):246-256. PubMed ID: 29336238
[TBL] [Abstract][Full Text] [Related]
3. Abnormal acetylation of FOXP3 regulated by SIRT-1 induces Treg functional deficiency in patients with abdominal aortic aneurysms.
Jiang H; Xin S; Yan Y; Lun Y; Yang X; Zhang J
Atherosclerosis; 2018 Apr; 271():182-192. PubMed ID: 29524861
[TBL] [Abstract][Full Text] [Related]
4. Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation.
Li J; Du X; Shi H; Deng K; Chi H; Tao W
J Biol Chem; 2015 Dec; 290(52):30762-70. PubMed ID: 26538561
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism.
Zhou J; Bi M; Fan C; Song X; Yang R; Zhao S; Li L; Li Y; Teng W; Shan Z
Clin Exp Med; 2012 Mar; 12(1):39-46. PubMed ID: 21544672
[TBL] [Abstract][Full Text] [Related]
6. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
[TBL] [Abstract][Full Text] [Related]
7. Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.
Yuan Q; Zhao Y; Zhu X; Liu X
J Endocrinol Invest; 2017 Apr; 40(4):397-407. PubMed ID: 27822606
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of circ_003912 contributes to pathogenesis of erosive oral lichen planus by via sponging microRNA-123, -647 and -31 and upregulating FOXP3.
Huang Z; Liu F; Wang W; Ouyang S; Sang T; Huang Z; Liao L; Wu J
Mol Med; 2021 Oct; 27(1):132. PubMed ID: 34670484
[TBL] [Abstract][Full Text] [Related]
9. Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p.
Shi QZ; Yu HM; Chen HM; Liu M; Cheng X
Clin Exp Med; 2021 Aug; 21(3):429-437. PubMed ID: 33779886
[TBL] [Abstract][Full Text] [Related]
10. Function of regulatory T-cells improved by dexamethasone in Graves' disease.
Hu Y; Tian W; Zhang LL; Liu H; Yin GP; He BS; Mao XM
Eur J Endocrinol; 2012 Apr; 166(4):641-6. PubMed ID: 22219499
[TBL] [Abstract][Full Text] [Related]
11. MiR-133a/133b inhibits Treg differentiation in IgA nephropathy through targeting FOXP3.
Jin LW; Ye HY; Xu XY; Zheng Y; Chen Y
Biomed Pharmacother; 2018 May; 101():195-200. PubMed ID: 29494956
[TBL] [Abstract][Full Text] [Related]
12. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
13. Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells.
Kwon HS; Lim HW; Wu J; Schnölzer M; Verdin E; Ott M
J Immunol; 2012 Mar; 188(6):2712-21. PubMed ID: 22312127
[TBL] [Abstract][Full Text] [Related]
14. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
[TBL] [Abstract][Full Text] [Related]
15. Increased Circulating Th17 but Decreased CD4
Qin J; Zhou J; Fan C; Zhao N; Liu Y; Wang S; Cui X; Huang M; Guan H; Li Y; Shan Z; Teng W
Biomed Res Int; 2017; 2017():8431838. PubMed ID: 29259988
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease.
Zheng L; Zhuang C; Wang X; Ming L
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28569050
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of miR-338-3p impairs Treg-mediated immunosuppression in pemphigus vulgaris by targeting RUNX1.
Xu M; Liu Q; Li S; Zhang W; Huang X; Han K; Li C; Zeng K
Exp Dermatol; 2020 Jul; 29(7):623-629. PubMed ID: 32386260
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin.
Kahaly GJ; Shimony O; Gellman YN; Lytton SD; Eshkar-Sebban L; Rosenblum N; Refaeli E; Kassem S; Ilany J; Naor D
J Clin Endocrinol Metab; 2011 Feb; 96(2):422-9. PubMed ID: 21147887
[TBL] [Abstract][Full Text] [Related]
19. MiR-363-5p modulates regulatory T cells through STAT4-HSPB1-Notch1 axis and is associated with the immunological abnormality in Graves' disease.
Yin X; Ge J; Ge X; Gao J; Su X; Wang X; Zhang Q; Wang Z
J Cell Mol Med; 2021 Oct; 25(19):9364-9377. PubMed ID: 34431214
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.
van Loosdregt J; Vercoulen Y; Guichelaar T; Gent YY; Beekman JM; van Beekum O; Brenkman AB; Hijnen DJ; Mutis T; Kalkhoven E; Prakken BJ; Coffer PJ
Blood; 2010 Feb; 115(5):965-74. PubMed ID: 19996091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
